And those are the kinds of issues we will address both in our partnership meetings tomorrow with our ISAF partners, but the -- a corepartner meeting that the President will be present with all the other leaders of 13 countries who are making significant political and military and other contributions to Alliance operations and what the Alliance does.
Biotech firms surveyed focused on four key factors: commitment from senior management, favorable deal terms, market depth in a particular therapeutic area and a strong alignment with a partner's core strategy.